
CRISPR whisperer in perpetual training. We're working to enable safe & accessible delivery of genome editing therapeutics. @igisci @UCBerkeley https://xitter.cf/t.co/89o53zRYUa
Joined December 2019
- Tweets453
- Following165
- Followers922
- Likes913
Ross Wilson retweeted
🧬 Can CRISPR dial down α-synuclein instead of knocking it out?
MTI winners Ross Wilson & Hanqin Li aim to halt Lewy bodies with precision base editing - $90 K + full platform support.
#CRISPR #Parkinsons #MTIAwards
🔗 Read more at moleculartherapeutics.org/20…
Ross Wilson retweeted
Inaugural post! (after a long hiatus)
Last May I quit my job to build @dittobio with @Mezarque and @emilycpierce ! We turn parasite molecules into drugs for autoimmune disease, and are part of the @ycombinator W26 batch.
Thanks for betting on us @agupta
Ross Wilson retweeted
New Strategy Enhances CRISPR Editing Efficiency for Therapeutic Use
In a new April 2025 @CRISPRjournal published study, IGI @UCBerkeley researchers leverage new constructs for NLS sequences to improve editing efficiency in human immune cells
#crispr
hubs.li/Q03hZVqv0
Ross Wilson retweeted
CRISPR has the potential to cure many genetic diseases, but it’s notoriously hard to use in neurons.
In this work we tackled 2 of the main hurdles: Cas9 delivery and DNA repair.
And we discovered…
The rules of genome editing are different in neurons👇🏾
biorxiv.org/content/10.1101/…
Ross Wilson retweeted
Here in this winter wonderland at Banff 🇨🇦 for the Keystone conference on Precision Genome Engineering #KSGenomeEng24 #KSNADelivery24
I’ll be presenting a poster on peptide mediated delivery of CRISPR RNPs in T cells tomorrow, stop by if around (poster 2526)! @RossWilsonLab
Ross Wilson retweeted
Excited to share a milestone in our forward genetics developments! Today in @Nature we report massive mutagenesis screening in T cells with base editors, increasing resolution from genes to nucleotides nature.com/articles/s41586-0…
A @MarsonLab story with my dear friend @carlcward
1/10
Ross Wilson retweeted
Happy Holidays from the Wilson Lab ❤️❄️
I wonder what Santa will be DELIVERing for us 🎅🏾🎄
Ross Wilson retweeted
First approval for a #CRISPR therapy in the world. UK MHRA has authorized Exagamglogene autotemcel (Casgevy) this morning. What a historic and uplifting day for patients and for the gene & cell therapy field. gov.uk/government/news/mhra-…
Ross Wilson retweeted
This week I am at @NIH attending the Martin Delaney collaboratories for HIV cure research (MDC) meeting, where I am presenting my work in @RossWilsonLab @igisci on delivery of base editors for @rid_hiv research
Ross Wilson retweeted
Wilson Lab: Inside IGI edition 🧬 @igisci @berkeleyMCB
Ross Wilson retweeted
Wilson Lab @ the @igisci happy hour 🍻
Ross Wilson retweeted
Presented on our peptide mediated delivery of RNP to the brain on behalf of the @RossWilsonLab and our amazing collaboration with @TNeuroSci_Lab and the Murthy Lab at the #cshlcrispr23 meeting 🧠💉
@igisci @berkeleyMCB
Ross Wilson retweeted
Amidst the tranquility of the beautiful @CSHL campus and riveting CRISPR scientists from around the world, I will be presenting a poster on our peptide-enabled delivery method (PERC) tomorrow at #cshlcrispr23
@RossWilsonLab @igisci @cshlmeetings
Ross Wilson retweeted
CSHL Genome Engineering : day 1! @srishtiupasana @LorendelaOM
It’s such a pleasure to be here representing Wilson Lab and to be giving a talk in the therapeutics section on saturday on some really exciting 🧠 editing! Stay tuned!
Ross Wilson retweeted
Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs #genetherapy #celltherapy dlvr.it/SrghB9
Ross Wilson retweeted
A new report from @zhangf and colleagues introduces an exciting new vehicle with potential for delivering molecular therapeutics into cells based on contractile injection systems.
Check out the full Views & News by @baehr_chris @RossWilsonLab
liebertpub.com/doi/10.1089/g…
Ross Wilson retweeted
One more step toward the first gene-editing drugs.
- FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
- FDA grants Priority Review for severe sickle cell disease (SCD)
ir.crisprtx.com/news-release…
Ross Wilson retweeted
Don't miss this event presented by UCSF Alpha Clinic, in collaboration with the Sickle Cell Anemia Association of San Francisco to learn about advances in #genetherapy for #SickleCellAnemia.
Register for the virtual event: Sat, June 3rd, 11am-1:30pm PST. bit.ly/3N9lPff
Ross Wilson retweeted
Amphiphilic peptides can aid the delivery of CRISPR ribonucleoproteins into primary human lymphocytes at low toxicity, boosting editing yields with respect to the use of electroporation.
rdcu.be/dcG8y [N&V]
rdcu.be/dcG8A [Paper]
Ross Wilson retweeted
New cover!!
After putting in hours of hard work, I truly deserve a delicious cup of coffee, and it brings me joy to see my image on the cover. Now, with an extra boost of caffeine, I'll continue creating nice images.❤
Peptide-boosted uptake of CRISPR enzymes
This issue highlights that prime editing can efficiently correct the sickle-cell allele in patient haematopoietic stem cells, a Cas9-based gene therapy for Huntington’s disease tested in pigs, the efficient peptide-mediated delivery of CRISPR enzymes, a method for the knock-in and stable expression of large payloads in primary human cells, that adding cytosine stretches to the 5′ end of single-guide RNAs constrains the activity of Cas9, and a library of cytosine base editors for the precise ablation of every mtDNA protein-coding gene in the mouse mitochondrial genome.
The cover illustrates that a peptide identified via screening aids the delivery of CRISPR ribonucleoprotein into cells, increasing the yield of edited primary human lymphocytes.
#ella_maru_studio #ella_maru #sciart #science #medcalillustration #medicalartist #sciencegirl #biology #chemistry #phdlife #journalcover #phd #scicomm #womaninscience #medicalartist #sciencegirl #biology #Chemistry




































